Canada markets closed

Basilea Pharmaceutica AG (BPMUF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
44.450.00 (0.00%)
At close: 01:56PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 528.25M
Enterprise Value 603.38M
Trailing P/E 47.13
Forward P/E 19.76
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)3.12
Price/Book (mrq)N/A
Enterprise Value/Revenue 3.83
Enterprise Value/EBITDA 25.96

Trading Information

Stock Price History

Beta (5Y Monthly) 0.58
52-Week Change 3-14.52%
S&P500 52-Week Change 321.08%
52 Week High 352.00
52 Week Low 338.60
50-Day Moving Average 341.64
200-Day Moving Average 344.08

Share Statistics

Avg Vol (3 month) 38
Avg Vol (10 day) 3N/A
Shares Outstanding 512M
Implied Shares Outstanding 612.01M
Float 811.63M
% Held by Insiders 10.06%
% Held by Institutions 137.04%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CHF.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 6.63%
Operating Margin (ttm)-22.51%

Management Effectiveness

Return on Assets (ttm)6.95%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)157.63M
Revenue Per Share (ttm)13.15
Quarterly Revenue Growth (yoy)-19.30%
Gross Profit (ttm)N/A
EBITDA 23.18M
Net Income Avi to Common (ttm)10.45M
Diluted EPS (ttm)0.94
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)59.93M
Total Cash Per Share (mrq)4.99
Total Debt (mrq)128.61M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.20
Book Value Per Share (mrq)-0.83

Cash Flow Statement

Operating Cash Flow (ttm)14.24M
Levered Free Cash Flow (ttm)8.51M